Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00605007 · ClinicalTrials.gov registry record
Study on COPD Corticosteroid-induced Hyperglycemia on Clinical Outcome in Patients With COPD
A clinical trial, sponsored by Emory University.
- Completed
- Registry status
- 450
- Enrollment target
NCT00605007 is a clinical trial that has completed, run by Emory University. The registered enrollment target is 450 participants.
The verdict
NCT00605007 has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- 450 participants
- Enrollment target
Study Summary
Hyperglycemia is a common complication of corticosteroid (cortisone) therapy. It is estimated that more than a third of patients with chronic pulmonary disease (COPD) exacerbation (16). Despite its frequency, the impact of corticosteroid-induced diabetes on clinical outcome and mortality is not known. A computerized search of biomedical journal literature from MEDLINE, PubMed, and Ovid from 1966 to 2006 provided very little information on the prevalence and outcome of corticosteroid-induced diabetes in patients with COPD. Therefore, the present study aims to evaluate the impact of corticosteroid-induced diabetes on clinical outcome in patients with COPD exacerbation. We will perform a retrospective chart review of all patients admitted to the hospital with COPD exacerbation from 1/01/05 to 06/30/06 at Grady Memorial Hospital. Medical records of all patients with COPD exacerbation treated with corticosteroids will be analyzed. Data on demographics, laboratory values, mortality rate, rate of hypoglycemic events, length of stay, as well as disposition at discharge will be analyzed.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 450 participants |
| Start Date | 2006-02 |
| Est. Completion | 2009-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00605007
The ClinicalTrials.gov registry entry for NCT00605007 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 450 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00605007 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00605007 about?
NCT00605007 is a clinical study titled "Study on COPD Corticosteroid-induced Hyperglycemia on Clinical Outcome in Patients With COPD". Hyperglycemia is a common complication of corticosteroid (cortisone) therapy. It is estimated that more than a third of patients with chronic pulmonary disease (COPD) exacerbation (16). Despite its frequency, the impact of corticosteroid-induced diabetes on clinical outcome and mortality is not know...
What is the current status of trial NCT00605007?
This trial is currently completed. The enrollment target is 450 participants. The study started on 2006-02. Estimated completion is 2009-12.
Who is sponsoring clinical trial NCT00605007?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.